window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Immunotherapy

  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Aravax adds allergy specialists to board as peanut therapy advances

    Aravax has appointed two senior industry figures to its board [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Evogene and Shanghai Lishan Biopharmaceuticals enter exclusive licensing agreement for BMC128

    Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    CuraCell highlights T-cell therapy advances for solid tumors on World Cancer Day

    On World Cancer Day (today, February 4), CuraCell highlights its [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Scancell clears FDA IND for iSCIB1+ registrational Phase 3 trial in advanced melanoma

    Scancell Holdings has announced that the U.S. Food and Drug [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Accord Healthcare disappointed as people with ES-SCLC in Scotland denied access to serplulimab

    Patients in Scotland living with extensive-stage small cell lung cancer [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Enterome’s EO2463 receives FDA fast track designation for follicular lymphoma watch-and-wait treatment

    Enterome has received Fast Track designation from the US Food [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy

    CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    SynGenSys launches NK.SET synthetic promoter library to support NK cell therapy development

    SynGenSys, a biotechnology company developing synthetic gene promoter systems, has [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Trelleborg gains ISO certification for Costa Rica medtech plant
    Categories: Clinical & Regulatory, Manufacturing & Supply Chain, Medical devices
  • Merck launches bio-based HPLC solvents for pharma labs
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain
  • Alto starts Phase 2b ALTO-207 trial in treatment-resistant depression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top